These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 26507172

  • 1. Legal changes to increase access to naloxone for opioid overdose reversal in the United States.
    Davis CS, Carr D.
    Drug Alcohol Depend; 2015 Dec 01; 157():112-20. PubMed ID: 26507172
    [Abstract] [Full Text] [Related]

  • 2. Opioid-overdose laws association with opioid use and overdose mortality.
    McClellan C, Lambdin BH, Ali MM, Mutter R, Davis CS, Wheeler E, Pemberton M, Kral AH.
    Addict Behav; 2018 Nov 01; 86():90-95. PubMed ID: 29610001
    [Abstract] [Full Text] [Related]

  • 3. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL, Cherney S, Smart R.
    Drug Alcohol Depend; 2020 Apr 01; 209():107896. PubMed ID: 32058248
    [Abstract] [Full Text] [Related]

  • 4. State legal innovations to encourage naloxone dispensing.
    Davis C, Carr D.
    J Am Pharm Assoc (2003); 2017 Apr 01; 57(2S):S180-S184. PubMed ID: 28073688
    [Abstract] [Full Text] [Related]

  • 5. Emergency medical services naloxone access: a national systematic legal review.
    Davis CS, Southwell JK, Niehaus VR, Walley AY, Dailey MW.
    Acad Emerg Med; 2014 Oct 01; 21(10):1173-7. PubMed ID: 25308142
    [Abstract] [Full Text] [Related]

  • 6. Legal regimes surrounding naloxone access: considerations for prescribers.
    Brodrick JE, Brodrick CK, Adinoff B.
    Am J Drug Alcohol Abuse; 2016 Mar 01; 42(2):117-28. PubMed ID: 26809471
    [Abstract] [Full Text] [Related]

  • 7. Regional variation in states' naloxone accessibility laws in association with opioid overdose death rates-Observational study (STROBE compliant).
    You HS, Ha J, Kang CY, Kim L, Kim J, Shen JJ, Park SM, Chun SY, Hwang J, Yamashita T, Lee SW, Dounis G, Lee YJ, Han DH, Byun D, Yoo JW, Kang HT.
    Medicine (Baltimore); 2020 May 29; 99(22):e20033. PubMed ID: 32481373
    [Abstract] [Full Text] [Related]

  • 8. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH, Davis CS, Wheeler E, Tueller S, Kral AH.
    Drug Alcohol Depend; 2018 Jul 01; 188():370-376. PubMed ID: 29776688
    [Abstract] [Full Text] [Related]

  • 9. Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.
    Abouk R, Pacula RL, Powell D.
    JAMA Intern Med; 2019 Jun 01; 179(6):805-811. PubMed ID: 31058922
    [Abstract] [Full Text] [Related]

  • 10. State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies.
    Xu J, Mukherjee S.
    Drug Alcohol Depend; 2021 Oct 01; 227():109012. PubMed ID: 34482035
    [Abstract] [Full Text] [Related]

  • 11. The changing landscape of naloxone availability in the United States, 2011 - 2017.
    Freeman PR, Hankosky ER, Lofwall MR, Talbert JC.
    Drug Alcohol Depend; 2018 Oct 01; 191():361-364. PubMed ID: 30195192
    [Abstract] [Full Text] [Related]

  • 12. State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies.
    Xu J, Davis CS, Cruz M, Lurie P.
    Drug Alcohol Depend; 2018 Aug 01; 189():37-41. PubMed ID: 29860058
    [Abstract] [Full Text] [Related]

  • 13. Changing law from barrier to facilitator of opioid overdose prevention.
    Davis C, Webb D, Burris S.
    J Law Med Ethics; 2013 Mar 01; 41 Suppl 1():33-6. PubMed ID: 23590737
    [Abstract] [Full Text] [Related]

  • 14. Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid.
    Gertner AK, Domino ME, Davis CS.
    Drug Alcohol Depend; 2018 Sep 01; 190():37-41. PubMed ID: 29966851
    [Abstract] [Full Text] [Related]

  • 15. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
    Duvivier H, Gustafson S, Greutman M, Jangchup T, Harden AK, Reinhard A, Warshany K.
    J Am Pharm Assoc (2003); 2017 Sep 01; 57(2S):S135-S140. PubMed ID: 28292501
    [Abstract] [Full Text] [Related]

  • 16. Expanding access to naloxone in the United States.
    Doyon S, Aks SE, Schaeffer S, American Academy of Clinical Toxicology, American College of Medical Toxicology, American Association of Poison Control Centers.
    Clin Toxicol (Phila); 2014 Dec 01; 52(10):989-92. PubMed ID: 25283253
    [No Abstract] [Full Text] [Related]

  • 17. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B, Zhao W, Yang KC, Ahn YY, Perry BL.
    JAMA Netw Open; 2021 Feb 01; 4(2):e2036687. PubMed ID: 33576816
    [Abstract] [Full Text] [Related]

  • 18. Co-prescribing naloxone does not increase liability risk.
    Davis CS, Burris S, Beletsky L, Binswanger I.
    Subst Abus; 2016 Feb 01; 37(4):498-500. PubMed ID: 27648764
    [Abstract] [Full Text] [Related]

  • 19. Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States.
    Smart R, Pardo B, Davis CS.
    Addiction; 2021 Jan 01; 116(1):6-17. PubMed ID: 32533570
    [Abstract] [Full Text] [Related]

  • 20. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
    Dadiomov D, Bolshakova M, Mikhaeilyan M, Trotzky-Sirr R.
    Harm Reduct J; 2022 Jun 29; 19(1):69. PubMed ID: 35768817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.